These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6705280)

  • 21. Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy.
    Tamsma JT; van der Woude FJ; Lemkes HH
    Nephrol Dial Transplant; 1996 Jan; 11(1):182-5. PubMed ID: 8649631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
    Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
    Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
    Keltai M; Tonelli M; Mann JF; Sitkei E; Lewis BS; Hawken S; Mehta SR; Yusuf S;
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):312-8. PubMed ID: 17446813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind trial of ticlopidine in sickle cell disease.
    Semple MJ; Al-Hasani SF; Kioy P; Savidge GF
    Thromb Haemost; 1984 Jul; 51(3):303-6. PubMed ID: 6388012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease in Argentina. Design, organization and general characteristics of patients at entry. The EMATAP Group.
    Blanchard JF; Carreras LO
    Nouv Rev Fr Hematol (1978); 1992; 34(2):149-53. PubMed ID: 1502021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of a new platelet aggregation inhibitor, ticlopidine, in hemodialysis].
    Griffanti-Bartoli F; Altomonte F; Pitton L; Armani U; Piana A
    Arch Maragliano Patol Clin; 1979; 35(2):73-80. PubMed ID: 263724
    [No Abstract]   [Full Text] [Related]  

  • 30. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
    Donadio JV; Anderson CF; Mitchell JC; Holley KE; Ilstrup DM; Fuster V; Chesebro JH
    N Engl J Med; 1984 May; 310(22):1421-6. PubMed ID: 6371535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.
    Aukland A; Hurlow RA; George AJ; Stuart J
    J Clin Pathol; 1982 Jul; 35(7):740-3. PubMed ID: 7047575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of necrobiosis lipoidica with low-dose acetylsalicylic acid. A randomized double-blind trial.
    Beck HI; Bjerring P; Rasmussen I; Zachariae H; Stenbjerg S
    Acta Derm Venereol; 1985; 65(3):230-4. PubMed ID: 2411079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo.
    Katsumura T; Mishima Y; Kamiya K; Sakaguchi S; Tanabe T; Sakuma A
    Angiology; 1982 Jun; 33(6):357-67. PubMed ID: 7046521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.
    Gibb DM; Dunger D; Levin M; Grant D; Jones P; Barratt TM
    Arch Dis Child; 1990 Jan; 65(1):93-8. PubMed ID: 2405789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).
    Mirouze J
    Agents Actions Suppl; 1984; 15():230-58. PubMed ID: 6385649
    [No Abstract]   [Full Text] [Related]  

  • 37. Monitoring kidney function in diabetic nephropathy.
    Rossing P; Astrup AS; Smidt UM; Parving HH
    Diabetologia; 1994 Jul; 37(7):708-12. PubMed ID: 7958543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The antiaggregation effect of ticlopidine on blood platelets preliminary results and prospectives for studies in various diseases].
    Andriani A; Chiappetta MG; Fabiani M; Mosiello G; Beni A
    Clin Ter; 1983 Feb; 104(3):219-22. PubMed ID: 6345050
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
    Lecrubier C; Girard P; Noire P; Samama M
    Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946
    [No Abstract]   [Full Text] [Related]  

  • 40. Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis.
    Gröntoft KC; Mulec H; Gutierrez A; Olander R
    Scand J Urol Nephrol; 1985; 19(1):55-7. PubMed ID: 3895411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.